Phibro Animal Health Corporation (PAHC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.46B
Last updated: Nov 17, 2026 at 11:04 AM ET
Phibro Animal Health Corporation (PAHC) P/E Ratio & Valuation History
Phibro Animal Health (PAHC) trades at 10.7x trailing earnings and 0.9x sales. Its P/E of 10.7x is below its 5-year median of 12.9x. Its forward P/E is 13.8x. The median P/E across 11 similar companies is 10.3x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 22.5% lower over the next year. Its free cash flow yield is 1.5%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 10.7x |
| Forward P/E | 13.8x |
| Price to sales | 0.9x |
| Price to book | 3.4x |
| EV/EBITDA | 8.7x |
| Price to FCF | 65.6x |
| EV/FCF | 96.0x |
| PEG | 1.7 |
| FCF yield | 1.5% |
Historical Medians
Against its 10-year medians, its P/E is 36.7% below 16.9x, its P/S is 18.2% below 1.1x and its P/B is 17.1% below 4.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 10.7x | 12.9x | 16.9x |
| P/S | 0.9x | 0.8x | 1.1x |
| P/B | 3.4x | 3.1x | 4.1x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 10.2x in 2023 to 21.8x in 2017.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $37.36 | 13.3x | 1.0x | 4.6x |
| 2024 | $21.00 | 13.0x | 0.8x | 3.4x |
| 2023 | $11.58 | 10.2x | 0.5x | 1.7x |
| 2022 | $13.41 | 10.8x | 0.6x | 2.0x |
| 2021 | $20.42 | 16.0x | 0.9x | 3.5x |
| 2020 | $19.42 | 16.7x | 1.0x | 3.7x |
| 2019 | $24.83 | 19.9x | 1.2x | 4.6x |
| 2018 | $32.16 | 18.5x | 1.5x | 6.3x |
| 2017 | $33.50 | 21.8x | 1.7x | 8.0x |
| 2016 | $29.30 | 19.8x | 1.5x | 10.3x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PAHC
What is PAHC's forward P/E ratio?
Phibro Animal Health has a forward P/E ratio of 13.8x.
Is PAHC stock overvalued?
GNG's valuation label for PAHC is Fairly valued. Its P/E of 10.7x compares with a median of 10.3x across 11 similar companies.
What is PAHC's price to sales ratio?
Phibro Animal Health has a price to sales ratio of 0.9x.
What is Phibro Animal Health's average P/E ratio over 5 years?
Phibro Animal Health's median P/E over the last 5 years is 12.9x, from 60 month-end values through Oct 2026.
What is PAHC's PEG ratio?
Phibro Animal Health has a PEG ratio of 1.7.
PAHC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors